| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |